Co-Authors
This is a "connection" page, showing publications co-authored by Anton Pottegård and Nanna Johansen.
Connection Strength
0.904
-
Adverse outcomes and mortality in users of non-steroidal anti-inflammatory drugs who tested positive for SARS-CoV-2: A Danish nationwide cohort study. PLoS Med. 2020 09; 17(9):e1003308.
Score: 0.225
-
Existing Data Sources in Clinical Epidemiology: The Danish COVID-19 Cohort. Clin Epidemiol. 2020; 12:875-881.
Score: 0.224
-
Association of Nonsteroidal Anti-inflammatory Drug Use and Adverse Outcomes Among Patients Hospitalized With Influenza. JAMA Netw Open. 2020 07 01; 3(7):e2013880.
Score: 0.223
-
Venous Thromboembolism and Major Bleeding in Patients With Coronavirus Disease 2019 (COVID-19): A Nationwide, Population-Based Cohort Study. Clin Infect Dis. 2021 12 16; 73(12):2283-2293.
Score: 0.062
-
SARS-CoV-2 infection and adverse outcomes in users of ACE inhibitors and angiotensin-receptor blockers: a nationwide case-control and cohort analysis. Thorax. 2021 04; 76(4):370-379.
Score: 0.057
-
Characteristics and predictors of hospitalization and death in the first 11 122 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort. Int J Epidemiol. 2020 10 01; 49(5):1468-1481.
Score: 0.057
-
Renin-Angiotensin System Blockers and Adverse Outcomes of Influenza and Pneumonia: A Danish Cohort Study. J Am Heart Assoc. 2020 10 20; 9(19):e017297.
Score: 0.057